VNDA

HEALTHY

Vanda Pharmaceuticals Inc.

CIK: 0001347178

Strong Sell (70% confidence)

Last activity: Mar 2, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$220.47M

Total Cash $64.76M

Current Ratio 2.39

Insider	Sells	Net Value	Holdings
Polymeropoulos Mihael Hristos President and CEO	1	-$1.28M	2,704,496 shares $22.10M
Moran Kevin Patrick SVP, CFO & Treasurer	1	-$351K	411,380 shares $3.40M
Williams Timothy SVP & General Counsel	1	-$351K	377,450 shares $3.12M
Birznieks Gunther SVP, Business Development	1	-$351K	494,197 shares $4.08M
Wijkstrom Joakim SVP, Chief Marketing Officer	1	-$255K	333,469 shares $2.76M
Honore Tage OTHER	1	-$241K	93,469 shares $751K

SELL Polymeropoulos Mihael Hristos (President and CEO)

156,235 shares @ $8.17

$1.28M

Mar 2, 2026

Conviction: | View SEC Filing →

SELL Moran Kevin Patrick (SVP, CFO & Treasurer)

42,442 shares @ $8.27

$351K

Mar 2, 2026

Conviction: | View SEC Filing →

SELL Williams Timothy (SVP & General Counsel)

42,434 shares @ $8.27

$351K

Mar 2, 2026

Conviction: | View SEC Filing →

SELL Birznieks Gunther (SVP, Business Development)

42,431 shares @ $8.27

$351K

Mar 2, 2026

Conviction: | View SEC Filing →

SELL Wijkstrom Joakim (SVP, Chief Marketing Officer)

30,800 shares @ $8.27

$255K

Mar 2, 2026

Conviction: | View SEC Filing →

SELL Honore Tage (OTHER)

30,000 shares @ $8.03

$241K

Feb 23, 2026

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.